3-month-old baby choked to death while being fed Cerelac

Udupi, Apr 24: While several state governments and NGOs are actively working to provide essentials to the needy amid the COVID-19 lockdown, a fisherwoman in Karnataka's Udupi has proved that even a small gesture of help for others can make a huge difference in the society.
A fisherwoman, Sharadakka, distributed rice to 140 needy families in her neighbourhood during the ongoing lockdown. The contribution was made by spending all her life savings amounting to Rs 30,000. The amount was saved by her over a period of time in an effort to build a house for herself.
On Thursday Udupi Deputy Commissioner G. Jagadeesh visited her and ensured help to build her house.
"Spending her meagre earnings, Sharadakka generously filled many empty stomachs amid the nation-wide lockdown, which is a matter of pride," said the Deputy Commissioner.

Mangaluru, Jan 25: Hotelier Samtappa reportedly committed suicide by consuming poison in Kadaba taluk in the district on police said on Saturday.

The deceased was running a hotel named Hotel Samtappa here.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.